Ordentlich Peter 4
4 · Syndax Pharmaceuticals Inc · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Ordentlich Peter
Chief Technology Officer
Transactions
- Sale
Common Stock
2023-02-01$28.43/sh−69$1,962→ 0 total - Other
Common Stock
2023-01-31$17.32/sh+69$1,195→ 69 total - Award
Stock Options (Right to buy)
2023-02-02$28.55/sh+90,000$2,569,500→ 90,000 totalExercise: $28.55Exp: 2033-02-02→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 69 shares by the Reporting Person on 01/31/2023 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]1/48th of the shares subject to the option shall vest monthly over a four-year period.